Usher Syndrome: Correlation between Visual Field Size and Maximal ERG Response B-Wave Amplitude

  • Alessandro Iannaccone
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 533)


The evaluation of a patient affected with hereditary retinal degenerations is based on the combination of psychophysical (e.g., visual acuity, visual field) and objective measurements [(e.g., the electroretinogram (ERG)]. The ERG provides essential information on the amount and quality of functioning retina left. The a-wave of the full-field flash maximal ERG response reflects the combined activity of rod and cone photoreceptors, whereas the b-wave reflects the activity of both the rod-and the cone-driven postreceptoral pathways. Vision begins at the level of photoreceptors but is subsequently fine-tuned via a series of gain and filtering steps taking place both inside the retina and, of course, at the brain level. Therefore, among the ERG parameters, the b-wave of the full-field flash maximal ERG response offers, however imperfect it may be, the best approximation of the full visual potential of any given retina, as it already encompasses the gain of the visual response performed intraretinally by the bipolar cells. In addition, since both the rod-and cone-driven pathways can contribute to the detection of the test targets used conventionally to delimit visual fields with the Goldmann kinetic technique, the maximal ERG response b-wave is well suited also for correlation analysis between ERG and visual fields obtained under these conditions.


Visual Field Retinitis Pigmentosa Retinal Degeneration Usher Syndrome Usher Syndrome Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahmed, Z. M., Riazuddin, S., Bernstein, S. L., Ahmed, Z., Khan, S., Griffith, A. J., Morell, R. J., Friedman, T. B., Riazuddin, S. and Wilcox, E. R., 2001, Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F, Am JHum Genet. 69:25-34.PubMedCrossRefGoogle Scholar
  2. Alagramam, K. N., Yuan, H., Kuehn, M. H., Murcia, C. L., Wayne, S., Srisailpathy, C. R., Lowry, R. B., Knaus, R., Van Laer, L., Bernier, F. P., Schwartz, S., Lee, C., Morton, C. C., Mullins, R. F., Ramesh, A., Van Camp, G., Hageman, G. S., Woychik, R. P. and Smith, R. J., 2001, Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F, Hum Mol Genet. 10:1709-1718.PubMedCrossRefGoogle Scholar
  3. Astuto, L. M., Weston, M. D., Carney, C. A., Hoover, D. M., Cremers, C. W., Wagenaar, M., Moller, C., Smith, R. J., Pieke-Dahl, S., Greenberg, J., Ramesar, R., Jacobson, S. G., Ayuso, C., Heckenlively, J. R., Tamayo, M., Gorin, M. B., Reardon, W. and Kimberling, W. J., 2000, Genetic heterogeneity of Usher syndrome: analysis of 151 families with Usher type I, Am J Hum Genet. 67:1569-1574.PubMedCrossRefGoogle Scholar
  4. Bhattacharya, G., Miller, C., Kimberling, W. J., Jablonski, M. M. and Cosgrove, D., 2002, Localization and expression of usherin: a novel basement membrane protein defective in people with Usher's syndrome type Ila, Hear Res. 163:1-11.PubMedCrossRefGoogle Scholar
  5. Bitner-Glindzicz, M., Lindley, K. J., Rutland, P., Blaydon, D., Smith, V. V., Milla, P. J., Hussain, K., FurthLavi, J., Cosgrove, K. E., Shepherd, R. M., Barnes, P. D., O'Brien, R. E., Famdon, P. A., Sowden, J., Liu, X. Z., Scanlan, M. J., Malcolm, S., Dunne, M. J., Aynsley-Green, A. and Glaser, B., 2000, A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene, Nat Genet. 26:56-60.PubMedCrossRefGoogle Scholar
  6. Bolz, H., von Brederlow, B., Ramirez, A., Bryda, E. C., Kutsche, K., Nothwang, H. G., Seeliger, M., del C- Salcedo Cabrera, M., Vila, M. C., Molina, O. P., Gal, A. and Kubisch, C., 2001, Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D, Nat Genet. 27:108112.Google Scholar
  7. Bork, J. M., Peters, L. M., Riazuddin, S., Bernstein, S. L., Ahmed, Z. M., Ness, S. L., Polomeno, R., Ramesh, A., Schloss, M., Srisailpathy, C. R., Wayne, S., Bellman, S., Desmukh, D., Ahmed, Z., Khan, S. N., Kaloustian, V. M., Li, X. C., Lalwani, A., Riazuddin, S., Bitner-Glindzicz, M., Nance, W. E., Liu, X. Z., Wistow, G., Smith, R. J., Griffith, A. J., Wilcox, E. R., Friedman, T. B. and Morell, R. J., 2001, Usher syndrome ID and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23, Am JHum Genet. 68:26-37.PubMedCrossRefGoogle Scholar
  8. Di Palma, F., Holme, R. H., Bryda, E. C., Belyantseva, L A., Pellegrino, R., Kachar, B., Steel, K. P. and NobenTrauth, K., 2001, Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D, Nat Genet. 27:103-107.PubMedCrossRefGoogle Scholar
  9. Edwards, A., Fishman, G. A., Anderson, R. J., Grover, S. and Derlacki, D. J., 1998, Visual acuity and visual field impairment in Usher syndrome, Arch Ophthalmol. 116:165-168.PubMedGoogle Scholar
  10. Eudy, J. D., Weston, M. D., Yao, S., Hoover, D. M., Rehm, H. L., Ma-Edmonds, M., Yan, D., Ahmad, I., Cheng, J. J., Ayuso, C., Cremers, C., Davenport, S., Moller, C., Talmadge, C. B., Beisel, K. W., Tamayo, M., Morton, C. C., Swaroop, A., Kimberling, W. J. and Sumegi, J., 1998, Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa, Science. 280:1753-1757.PubMedCrossRefGoogle Scholar
  11. Fishman, G. A., Anderson, R. J., Lam, B. L. and Derlacki, D. J., 1995, Prevalence of foveal lesions in type 1 and type 2 Usher's syndrome, Arch Ophthalmol. 113:770-773.PubMedCrossRefGoogle Scholar
  12. Gouras, P., Arrington, J. C., Kropfl, W. J. and Gunkel, R. D., 1964, Electronic computation of human retinal and brain responses to light stimulation, NYAcad Sci. 115:763-775.Google Scholar
  13. Iannaccone, A., Rispoli, E., Vingolo, E. M., Onori, P., Steindl, K., Rispoli, D. and Pannarale, M. R., 1995, Correlation between Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa, Doc Ophthalmol. 90:129-142.PubMedCrossRefGoogle Scholar
  14. Lannaccone, A., Vingolo, E. M., Rispoli, E., De Propris, G., Tanzilli, P. and Pannarale, M. R., 1996, Electroretinographic alterations in the Laurence-Moon-Bardet-Biedl phenotype, Acta Ophthalmol Scand 74:8-13.CrossRefGoogle Scholar
  15. Joensuu, T., Hamalainen, R., Yuan, B., Johnson, C., Tegelberg, S., Gasparini, P., Zelante, L., Pirvola, U., Pakarinen, L., Lehesjoki, A. E., de la Chapelle, A. and Sankila, E.-M., 2001, Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3, Am J Hum Genet. 69:673-684.PubMedCrossRefGoogle Scholar
  16. Leroy, B. P., Aragon-Martin, J. A., Weston, M. D., Bessant, D. A., Willis, C., Webster, A. R., Bird, A. C., Kimberling, W. J., Payne, A. M. and Bhattacharya, S. S., 2001, Spectrum of mutations in USH2A in British patients with Usher syndrome type Il, Exp Eye Res. 72:503-509.PubMedCrossRefGoogle Scholar
  17. Najera, C., Beneyto, M., Blanca, J., Aller, E., Fontcuberta, A., Milian, J. M. and Ayuso, C., 2002, Mutations in myosin VILA (MYO7A) and usherin (USH2A) in Spanish patients with Usher syndrome types I and II, respectively, Hum Mutat. 20:76-77.PubMedCrossRefGoogle Scholar
  18. Rispoli, E., Iannaccone, A. and Vingolo, E. M., 1994, Low-noise electroretinogram recording techniques in retinitis pigmentosa, Doc Ophthalmol. 88:27-37.PubMedCrossRefGoogle Scholar
  19. Rivolta, C., Sweklo, E. A., Berson, E. L. and Dryja, T. P., 2000, Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss, Am J Hum Genet. 66:1975-1978.PubMedCrossRefGoogle Scholar
  20. Sandberg, M. A., Weigel-DiFranco, C., Rosner, B. and Berson, E. L., 1996, The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa, Invest Ophthalmol Vis Sci. 37:16931698.Google Scholar
  21. Seeliger, M., Pfister, M., Gendo, K., Paasch, S., Apfelstedt-Sylla, E., Plinkert, P., Zenner, H. P. and Zrenner, E., 1999, Comparative study of visual, auditory, and olfactory function in Usher syndrome, Graefes Arch Clin Exp Ophthalmol. 237:301-307.PubMedCrossRefGoogle Scholar
  22. Sieving, P. A., Arnold, E. B., Jamison, J., Liepa, A. and Coats, C., 1998, Submicrovolt flicker electroretinogram: cycle-by-cycle recording of multiple harmonics with statistical estimation of measurement uncertainty, Invest Ophthalmol Vis Sci. 39:1462-1469.PubMedGoogle Scholar
  23. Weil, D., Blanchard, S., Kaplan, J., Guilford, P., Gibson, F., Walsh, J., Mburu, P., Varela, A., Levilliers, J., Weston, M. D. and et, a., 1995, Defective myosin VILA gene responsible for Usher syndrome type 1B, Nature. 374:60-61.PubMedCrossRefGoogle Scholar
  24. Weston, M. D., Kelley, P. M., Overbeck, L. D., Wagenaar, M., Orten, D. J., Hasson, T., Chen, Z. Y., Corey, D., Mooseker, M., Sumegi, J., Cremers, C., Moller, C., Jacobson, S. G., Gorin, M. B. and Kimberling, W. J., 1996, Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients, Am J Hum Genet. 59:1074-1083. PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Alessandro Iannaccone
    • 1
  1. 1.Department of OphthalmologyUniversity of Tennessee Health Science CenterTNUSA

Personalised recommendations